Inotiv Inc. recently announced that the U.S. Securities and Exchange Commission $(SEC.UK)$ has concluded its investigation into the company's importation of non-human primates from Asia. The investigation, which began with a voluntary request for documents and information in May 2023, focused on whether Inotiv, along with Envigo Global Services, Inc. and Orient BioResource Center, Inc., complied with the U.S. Foreign Corrupt Practices Act. The SEC issued a formal order of investigation in January 2024 and provided supplemental document requests in April 2024. As of June 2, 2025, the SEC's Division of Enforcement has decided not to recommend any enforcement action against Inotiv based on the information available.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。